Publisher
Springer Berlin Heidelberg
Reference39 articles.
1. Agarwal M, Thomas K, Peter JV, Jeyaseelan L, Cherian AM (1998) A randomized double-blind sham-controlled study of intrathecal human anti-tetanus immunoglobulin in the management of tetanus. Natl Med J India 11:209–912
2. Andresen I, Kovarik JM, Spycher M, Bolli R (2000) Product equivalence study comparing the tolerability, pharmacokinetics, and pharmacodynamics of various human immunoglobulin-G formulations. J Clin Pharmacol 40:722–730
3. Anonymous (1999) Report of an IUIS Scientific Committee: Primary Immunodeficiency Diseases. Clin exp Immunol 118 (Suppl):1–28
4. Berger A, Doerr HW, Scharrer I, Weber B (1997) Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission. J Med Virol 53:25–30
5. Buchwald B, Ahangari R, Weishaupt A, Toyka KV (2002) Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann Neurol 51:673–680